| 000 | 01043cam a2200157 4500500 | ||
|---|---|---|---|
| 005 | 20250413023639.0 | ||
| 041 | _afre | ||
| 042 | _adc | ||
| 100 | 1 | 0 |
_ade La Rosa, Stéphane _eauthor |
| 245 | 0 | 0 | _aSovereignty and Health: Juridical Challenges for Europe |
| 260 | _c2024. | ||
| 500 | _a53 | ||
| 520 | _aTogether with a general discourse about European sovereignty, refer- ences to health sovereignty have multiplied since the sanitary crisis. In spite of its rather general formulation, health sovereignty refers to a mixture of transformations and evolutions in numerous sectors of European health law regarding drug approval, pharmacovigilance, financing and institutional supervision. Conceived at first essentially as a way of reducing dependency from other countries, health sovereignty can only materialise through major evolutions of European health law. | ||
| 786 | 0 | _nPouvoirs | o 190 | 3 | 2024-08-19 | p. 91-101 | 0152-0768 | |
| 856 | 4 | 1 | _uhttps://shs.cairn.info/journal-pouvoirs-2024-3-page-91?lang=en&redirect-ssocas=7080 |
| 999 |
_c1121526 _d1121526 |
||